| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |